<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03590678</url>
  </required_header>
  <id_info>
    <org_study_id>RGH-015</org_study_id>
    <nct_id>NCT03590678</nct_id>
  </id_info>
  <brief_title>Collection of Whole Blood Specimens in Pregnant Women</brief_title>
  <official_title>Prospective Collection of Whole Blood Specimens in Pregnant Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Illumina, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Illumina, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To prospectively collect whole blood specimens and clinical data from pregnant women
      scheduled for an invasive prenatal diagnostic procedure (&quot;invasive procedure&quot;). Specimens
      will be used for future testing with an investigational NIPT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective multicenter study in which whole blood specimens will be collected from
      pregnant women scheduled for an invasive procedure.

      After the standard-of-care invasive procedure is performed in accordance with the site's
      clinical procedures, invasive prenatal diagnostic procedure results will also be collected.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 13, 2017</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">August 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Collect Whole Blood Specimens in Pregnant Women</measure>
    <time_frame>3 years</time_frame>
    <description>To collect maternal whole blood specimens from approximately 5,150 women with corresponding cytogenetic results from invasive prenatal diagnostic procedures (performed per the standard of care) to achieve sample size goals</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">3000</enrollment>
  <condition>Pregnancy Related</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Subject is scheduled for an invasive procedure and did not have NIPT testing in current pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Subject is scheduled for an invasive procedure and has a known positive or no-call result from a targeted NIPT in the current pregnancy</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Human blood specimens will be spun to plasma and stored at -80C freezers
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women with a viable pregnancy of at least 10 weeks, 0 days gestation who are scheduled for
        an invasive procedure performed per the standard of care.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be 18 years of age or older at enrollment,

          -  Has a viable pregnancy (with documented fetal heartbeat) of at least 10 weeks, 0 days
             gestation at the time of maternal specimen collection,

          -  Be scheduled for an invasive prenatal diagnostic procedure (either chorionic villus
             sampling [CVS], amniocentesis, or percutaneous umbilical cord blood sampling
             [cordocentesis]) for cytogenetic analysis of the fetus

        Exclusion Criteria:

          -  Has a known maternal chromosomal anomaly,

          -  Had an invasive prenatal diagnostic procedure in the current pregnancy before maternal
             specimen collection

          -  Has a history of transplant or malignancy, or

          -  Had a transfusion of blood or blood components up to 8 weeks before maternal whole
             blood specimen collection

          -  Already participated in this study (enrolled previously).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kathryn Waldrep, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical City Dallas Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Fetal Medicine</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maternal Fetal Medicine and Genetics</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Desert Perinatal Associates</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89148</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Practice Research Organization</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Virgina Medical School, Dept Obstetrics and Gynecology, Maternal Fetal Medicine</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kuala Lumpur Hospital</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Angelius Provita</name>
      <address>
        <city>Katowice</city>
        <state>Silesia</state>
        <zip>40-611</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CENTRUM INNOWACYJNYCH TERAPII Sp. z</name>
      <address>
        <city>Piaseczno</city>
        <zip>05-500</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FERTINA Sp. z o.o. SPÓŁKA KOMANDYTOWA</name>
      <address>
        <city>Warszawa</city>
        <zip>00-172</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phramongkutklao Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maharaj Nakorn Chiang Mai Hospital</name>
      <address>
        <city>Chiang Mai</city>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Songklanagarind Hospital</name>
      <address>
        <city>Songkhla</city>
        <zip>90110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Institute of general practice - family medicine&quot;</name>
      <address>
        <city>Kyiv</city>
        <zip>02132</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LLC &quot;Reproductive Genetics Clinic &quot;Victoria&quot;</name>
      <address>
        <city>Kyiv</city>
        <zip>04070</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center &quot;Pulse&quot;, Small Private Business</name>
      <address>
        <city>Vinnytsya</city>
        <zip>21001</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
    <country>Poland</country>
    <country>Thailand</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 4, 2017</study_first_submitted>
  <study_first_submitted_qc>July 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2018</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

